Anuh Pharma Ltd

Thu 27/08/2026,15:57:41 | NSE : ANUHPHR

₹83.584.56 (5.77%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 79.97

Previous Close

₹ 79.02

Volume

339632

Mkt Cap ( ₹ Cr)

₹ 837.67

High

₹ 84.39

Low

₹ 78.45

52 Week High

₹ 93.00

52 Week Low

₹ 67.00

Book Value Per Share

₹ 36.28

Dividend Yield

1.90

Face Value

₹ 5.00

What's Your Call?

Collective community sentiment on Anuh Pharma Ltd

Your Vote -

Buy

85.71%

Hold

9.52%

Sell

4.76%

85.71%

21 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

83.58

7679

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

7679

Option Chain

Analyzes market sentiment, predicts Anuh Pharma Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Anuh Pharma Q1 net profit up 37.59% at Rs 11.42 cr

    22 Aug 2026, 6:00PM The company reported standalone net profit of Rs 11.42 crore for the quarter ended June 30, 2026 as compared to Rs 8.30 crore in the same period last

  • Anuh Pharma - Investor Presentation

    19 Aug 2026, 4:54PM Anuh Pharma Limited has informed the Exchange about Investor Presentation

  • Anuh Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation

    19 Aug 2026, 4:47PM Investor Presentation for Q1 FY 2026-27

  • Anuh Pharma - Announcement under Regulation 30 (LODR)-Change in Management

    14 Aug 2026, 11:36PM Disclosure under Regulation 30 of SEBI (LODR), 2015 regarding Change in Management.

  • Anuh Pharma - Change in Management

    14 Aug 2026, 11:33PM Anuh Pharma Limited has informed the Exchange about change in Management

  • Anuh Pharma - Appointment

    14 Aug 2026, 11:32PM Anuh Pharma Limited has informed the Exchange regarding Appointment of Mr Bipin N. Shah, Mr. Arun L. Todarwal and Mr. Ankit Chande as Directors of the

  • Anuh Pharma - General Updates

    14 Aug 2026, 11:23PM Anuh Pharma Limited has informed the Exchange about General Updates under Regulation 30.

  • Anuh Pharma - Announcement Under Regulation 30 - General Updates

    14 Aug 2026, 11:20PM Disclosure of Announcement under Regulation 30 of SEBI (LODR), 2015

  • Anuh Pharma - Shareholders meeting

    14 Aug 2026, 10:45PM Anuh Pharma Limited has submitted the Exchange a copy Voting Results and Scrutinizers report of Annual General Meeting held on August 12, 2026.

  • Anuh Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Aug 2026, 10:42PM Submission of Scrutinizer Report and Voting Results for the 66th Annual General Meeting of the Company

  • Anuh Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Aug 2026, 10:42PM Submission of Scrutinizer Report and Voting Results for the 66th Annual General Meeting of the Company

  • Anuh Pharma - Shareholders meeting

    12 Aug 2026, 9:13PM Anuh Pharma Limited has informed the Exchange regarding Proceedings of 66th Annual General Meeting held on August 12, 2026

  • Anuh Pharma - Shareholder Meeting / Postal Ballot-Outcome of AGM

    12 Aug 2026, 9:09PM Outcome of the 66th Annual General Meeting of Anuh Pharma Limited held on Wednesday, 12th August, 2026

  • Anuh Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Aug 2026, 10:42PM Submission of Scrutinizer Report and Voting Results for the 66th Annual General Meeting of the Company

  • Anuh Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Aug 2026, 10:42PM Submission of Scrutinizer Report and Voting Results for the 66th Annual General Meeting of the Company

  • Anuh Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Aug 2026, 10:42PM Submission of Scrutinizer Report and Voting Results for the 66th Annual General Meeting of the Company

  • Anuh Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Aug 2026, 10:42PM Submission of Scrutinizer Report and Voting Results for the 66th Annual General Meeting of the Company

  • Anuh Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Aug 2026, 10:42PM Submission of Scrutinizer Report and Voting Results for the 66th Annual General Meeting of the Company

  • Anuh Pharma - Copy of Newspaper Publication

    9 Aug 2026, 4:48PM Anuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication of the Unaudited financial results for the Quarter ended 30th June,

  • Anuh Pharma - Updates

    7 Aug 2026, 6:56PM Anuh Pharma Limited has informed the Exchange regarding 'Adoption of Revised Policy of Related Party Transactions.'.

  • Anuh Pharma - Announcement Under Regulation 30 (LODR) - Adoption Of Revised Policy Of Related Party Transactions,

    7 Aug 2026, 6:52PM Adoption of Revised Policy of Related Party Transactions.

  • Anuh Pharma - Updates

    7 Aug 2026, 6:47PM Anuh Pharma Limited has informed the Exchange regarding 'Request received for Withdrawal of application for reclassification of shareholding from Prom

  • Anuh Pharma - Announcement Under Regulation 30 (LODR) - Intimation Regarding The Request Received For Withdrawal Of Applicati

    7 Aug 2026, 6:44PM Request received for Withdrawal of application for reclassification of shareholding from \Promoter & Promoter Group' to 'Public Category'.

  • Anuh Pharma - Results - Financial Results For June 30, 2026

    7 Aug 2026, 6:32PM Unaudited Financial Results for the Quarter ended 30th June, 2026.

  • Anuh Pharma - Updates

    7 Aug 2026, 6:17PM Anuh Pharma Limited has informed the Exchange regarding 'Financial Results'.

  • Anuh Pharma - Outcome of Board Meeting

    7 Aug 2026, 6:03PM Anuh Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

  • Anuh Pharma - Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On 07/08/2026

    7 Aug 2026, 5:52PM To consider and approve the Unaudited Financial results along with the Limited Review Report for the quarter ended 30th June, 2026, Request received f

  • Anuh Pharma - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 30

    3 Aug 2026, 4:42PM Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and appr

  • Anuh Pharma has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    21 Jul 2026, 5:00PM As of June 2026, 71.80% is owned by Promoters and 28.20% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 71.78% and Forei

  • Anuh Pharma - General Updates

    18 Jul 2026, 5:12PM Anuh Pharma Limited has informed the Exchange regarding dispatch of physical communication to shareholders who have not registered their email address

  • Anuh Pharma - Copy of Newspaper Publication

    18 Jul 2026, 4:55PM Anuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication

  • Anuh Pharma - Shareholders meeting

    18 Jul 2026, 4:11PM Anuh Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 12, 2026

  • Anuh Pharma - General Updates

    18 Jul 2026, 5:08PM This is to inform to the stock exchange regarding dispatch of physical communication to shareholders who have not registered their email address.

  • Anuh Pharma - Reg. 34 (1) Annual Report.

    18 Jul 2026, 4:33PM Pursuant to the provisions of Regulation 34(1) of the SEBI (Listing Obligation and Disclosures Requirements) Regulations, 2015 please find enclosed he

  • Anuh Pharma - Shareholder Meeting - Annual General Meeting On Wednesday, 12Th August, 2026

    18 Jul 2026, 4:19PM In terms of the provisions of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find attached herewith Notice of the

  • Anuh Pharma has declared 30% Final dividend for the financial year March 2026

    14 Jul 2026, 6:01PM Anuh Pharma Ltd. on Wednesday, 20 May 2026, has announced Final dividend of 30 percent on Equity Share, to its shareholders holding shares on the regi

  • Anuh Pharma - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    14 Jul 2026, 1:39PM Anuh Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Anuh Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    14 Jul 2026, 1:34PM Compliance Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2026 re

  • Anuh Pharma - Trading Window

    26 Jun 2026, 3:54PM Anuh Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

  • Anuh Pharma - Copy of Newspaper Publication

    20 Jun 2026, 7:09PM Anuh Pharma Limited has informed the Exchange about Clarification for Newspaper Publication made on 19th June, 2026

  • Anuh Pharma - Clarification For Newspaper Publication

    20 Jun 2026, 7:06PM Clarification for Newspaper Publication made on 19th June, 2026

  • Anuh Pharma - Action(s) taken or orders passed

    19 Jun 2026, 5:53PM Anuh Pharma Limited has informed the Exchange about orders passed regarding receipt of Demand Order under Section 156 and Penalty Order under Section

  • Anuh Pharma - Copy of Newspaper Publication

    19 Jun 2026, 5:35PM Anuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication for transfer of equity shares of the Company for which Dividend has

  • Anuh Pharma - Investor Presentation

    28 May 2026, 5:28PM Anuh Pharma Limited has informed the Exchange about Investor Presentation

  • Anuh Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation

    28 May 2026, 5:24PM Investor Presentation for Q4 FY 2025-26

  • Anuh Pharma gets nod from WHO

    29 Sep 2020 , 10:28AM Anuh Pharma Ltd receives approval from WHO for Pyrimcthamine API
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Anuh Pharma Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 352.2224 336.5229 293.2313 241.2214 216.8838
Liabilities 352.2224 336.5229 293.2313 241.2214 216.8838
Equity 50.112 25.056 25.056 25.056 25.056
Gross Profit 61.7203 60.9087 75.1491 51.2745 46.8455
Net Profit 41.0461 47.3519 60.0575 36.1796 30.5613
Cash From Operating Activities -3.0116 37.1248 12.9251 53.9016 28.8637
NPM(%) 5.31 7.15 9.28 6.85 6.27
Revenue 771.6574 661.5149 647.0043 527.486 486.6462
Expenses 709.9371 600.6062 571.8552 476.2115 439.8007
ROE(%) 11.28 13.02 16.51 9.94 8.4

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
05 Aug 2026 1.5 30 1.79 81.19
14 Aug 2025 1.5 30 1.79 207.39

Peers

Other companies within the same industry or sector that are comparable to Anuh Pharma Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 890.25 2.36 22.52 45.03 -26.19 0.56
Lotus Eye Hospital and Institute Ltd 112.63 0.91 1609.00 164.08 0.39 0.00
Vaishali Pharma Ltd 8.33 1.96 26.03 1029.35 15.42 0.00
Astec Lifesciences Ltd 585.90 -1.28 0.00 175.81 -363.14 0.00

Company Info

1961 - Anuh Pharma Ltd was incorporated. 2006 - In early January, the promoters sold off nearly 14.9% of their stake in the company. -Anuh Pharma has given the Bonus in the Ratio of 1:1 -Company has splits its Face value of Shares from Rs 10 to Rs 5 2010 -Anuh Pharma has given the Bonus in the Ratio of 2:1 2011 -Anuh Pharma has recommended a Dividend of Rs. 5.00 per share of face value of Rs. 5.00. 2012 -Anuh Pharma Ltd has entered into a Memorandum of Understanding with M/s. Invent Pharma Pvt. Ltd., to acquire all fixed assets of their Research & Development Laboratory. -Anuh Pharma has recommended a dividend of Rs. 5.50 per equity share of face value of Rs. 5.00. 2013 -Anuh Pharma has recommended a dividend of Rs. 6.00 per equity share of face value of Rs. 5.00. 2014 -Anuh Pharma Ltd have received approval from COFEPRIS (Health Authority of Mexico) GMP certificate for three of Companys Erythromycin products namely Erythromycin Estolate, Erythromycin Ethyl Succinate & Erythromycin Stearate. -Anuh Pharma has recommended a Final Dividend of Rs. 6.50 (130%) per share. 2015 -The Company has allotted the Bonus Shares to its shareholders in the Ratio of 2:1. 2016 -Anu Pharma Ltd has received EUGMP Certificate granted by ANSM - France. 2020 -The Company has issued Bonus Shares in the Ratio of 1:1. 2025-The Company has issued Bonus Shares in the Ratio of 1:1.

1961 - Anuh Pharma Ltd was incorporated. 2006 - In early January, the promoters sold off nearly 14.9% of their stake in the company. -Anuh Pharma has given the Bonus in the Ratio of 1:1 -Company has splits its Face value of Shares from Rs 10 to Rs 5 2010 -Anuh Pharma has given the Bonus in the Ratio of 2:1 2011 -Anuh Pharma has recommended a Dividend of Rs. 5.00 per share of face value of Rs. 5.00. 2012 -Anuh Pharma Ltd has entered into a Memorandum of Understanding with M/s. Invent Pharma Pvt. Ltd., to acquire all fixed assets of their Research & Development Laboratory. -Anuh Pharma has recommended a dividend of Rs. 5.50 per equity share of face value of Rs. 5.00. 2013 -Anuh Pharma has recommended a dividend of Rs. 6.00 per equity share of face value of Rs. 5.00. 2014 -Anuh Pharma Ltd have received approval from COFEPRIS (Health Authority of Mexico) GMP certificate for three of Companys Erythromycin products namely Erythromycin Estolate, Erythromycin Ethyl Succinate & Erythromycin Stearate. -Anuh Pharma has recommended a Final Dividend of Rs. 6.50 (130%) per share. 2015 -The Company has allotted the Bonus Shares to its shareholders in the Ratio of 2:1. 2016 -Anu Pharma Ltd has received EUGMP Certificate granted by ANSM - France. 2020 -The Company has issued Bonus Shares in the Ratio of 1:1. 2025-The Company has issued Bonus Shares in the Ratio of 1:1.

Parent Organisation

Anuh Pharma Ltd.

Founded

19/02/1960

Managing Director

Mr.Ritesh Shah

NSE Symbol

ANUHPHREQ

FAQ